Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
Alkermes Plc (NASDAQ: ALKS) shares declined 2.78 percent to close at $39.86 a share Thursday. The stock traded between $39.45 and $40.28 on volume of 1.11 million shares traded. Analysts at UBS have recently downgraded the company’s rating to "neutral" from "buy". Shares of Alkermes have gained approximately 115.0 percent year-to-date.
Find out more about Alkermes including full access to the free equity report at:
www.RDInvesting.com/ALKS
Celgene Corporation (NASDAQ: CELG) shares increased 2.77 percent to close at $164.51 a share Thursday. The stock traded between $162.26 and $166.00 on volume of 3.28 million shares traded. Analysts at UBS have recently upgraded the company’s rating to "buy" from "neutral". Shares of Celgene have gained approximately 110.0 percent year-to-date.
Find out more about Celgene including full access to the free equity report at:
www.RDInvesting.com/CELG
Quality Distribution, Inc. (NASDAQ: QLTY) shares declined 3.59 percent to close at $12.62 a share Thursday. The stock traded between $12.02 and $12.83 on volume of 527,509 shares traded. Analysts at Stifel have recently downgraded the company’s rating to "hold" from "buy". Shares of Quality Distribution have gained approximately 110.0 percent year-to-date.
Find out more about Quality Distribution including full access to the free equity report at:
www.RDInvesting.com/QLTY
Spirit AeroSystems Holdings, Inc. (NYSE: SPR) shares increased 2.28 percent to close at $32.36 a share Thursday. The stock traded between $31.86 and $32.66 on volume of 1.79 million shares traded. Analysts at Canaccord Genuity have recently upgraded the company’s rating to "buy" from "hold". Shares of Spirit AeroSystems have gained approximately 90.0 percent year-to-date.
Find out more about Spirit AeroSystems including full access to the free equity report at:
www.RDInvesting.com/SPR
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
[email protected]